Targeting PARN in GSCs reduces tumor infiltration and prolongs survival in orthotopic brain tumor xenografts, suggesting that the STAT3-PARN regulatory network plays a pivotal role in tumor progression and represents a potential target for GBM therapeutics [70]. The gene discussed is STAT3; the disease is neoplasm.